Does LENALIDOMIDE Cause Diffuse large b-cell lymphoma refractory? 60 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Diffuse large b-cell lymphoma refractory have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.0% of all adverse event reports for LENALIDOMIDE.
60
Reports of Diffuse large b-cell lymphoma refractory with LENALIDOMIDE
0.0%
of all LENALIDOMIDE reports
27
Deaths
1
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From LENALIDOMIDE?
Of the 60 reports, 27 (45.0%) resulted in death, 1 (1.7%) required hospitalization.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 60 reports have been filed with the FAERS database.
What Other Side Effects Does LENALIDOMIDE Cause?
Diarrhoea (27,576)
Fatigue (22,956)
Death (19,213)
Off label use (17,017)
Rash (15,794)
Pneumonia (14,807)
Plasma cell myeloma (14,191)
Neuropathy peripheral (10,215)
White blood cell count decreased (9,996)
Constipation (9,635)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which LENALIDOMIDE Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
LENALIDOMIDE vs LENIOLISIB
LENALIDOMIDE vs LENOGRASTIM
LENALIDOMIDE vs LENVATINIB
LENALIDOMIDE vs LEPONEX
LENALIDOMIDE vs LERCANIDIPINE